World Lung Cancer Day (Aug 1): Documentation and Coding Resources for Your Practice

By August 1, 2024: Billing and clinical documentation teams must implement the following changes: (1) Providers and coders must update documentation templates to capture all required elements: type of neoplasm (primary/secondary/carcinoma in situ/benign/unspecified), diagnostic test types, specific treatment modalities with purpose (curative/palliative/preventive), and applicable risk factors from the Z-code list provided. (2) Billing team must update diagnosis code assignment protocols to enforce specificity (main bronchus, upper/middle/lower lobe, right/left side) and ensure codes are sequenced correctly per the policy examples (secondary malignancy first if treatment is directed to metastatic site, lung cancer before pleural effusion, etc.). (3) Coders must verify that all claims use only the highest specificity codes and reject use of unspecified codes (those marked †) unless no other code applies. (4) Update encounter forms and EMR systems to flag and prevent documentation errors identified in the 'Do Not' section (no uncertain language for confirmed malignancies, no 'history of' during active treatment, no suspected/unconfirmed diagnoses coded as confirmed). (5) Training must be provided to all clinical and billing staff on the three coding examples and the distinction between active malignancy coding, post-treatment surveillance codes (Z85.118), and screening codes (Z12.2). Failure to comply will result in claim denials and potential audit findings from Healthfirst.